Syntec Optics enables photonic biosensing for accelerated drug discovery

Syntec Optics (OPTX) announced its continued collaboration to enable development of a novel photonic biosensing technology poised to transform drug discovery and testing. Syntec Optics is providing critical optical manufacturing and sub-assembly processes to image laser light into our OEM’s photonic integrated circuits, enabling the integration of photonic sensors into micro physiological systems. Scientists can now observe how human cells respond to drugs in real time, significantly improving the accuracy and speed of drug development.